Overview of Dr. Frick
Kyle Frick, MD is a cardiologist specializing in interventional cardiology based in Indianapolis, IN. A graduate of Indiana University School of Medicine, he completed his residencies and fellowships at Indiana University School of Medicine and University of Texas Southwestern Medical Center. During his fellowship, he also held a position as Chief Cardiology Fellow at Indiana University School of Medicine. Dr. Frick's experience encompasses general cardiology, hypertension, coronary artery disease, interventional cardiology, and preventive cardiology. He has several publications to his name in reputable journals, related to different aspects of cardiology. His achievements include receiving the General Cardiology Fellowship Clinical Teacher of the Year from Indiana University School of Medicine in 2021 and the UT Southwestern Resident Teaching Award in 2014.
Office
1115 Ronald Reagan Pkwy
Avon, IN 46123Fax+1 317-274-7792
Education & Training
- Indiana University School of MedicineFellowship, Interventional Cardiology, 2017 - 2018
- Indiana University School of MedicineFellowship, Cardiovascular Disease, 2014 - 2017
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2011 - 2014
- Indiana University School of MedicineClass of 2011
- Indiana UniversityB.S., Biology, High Distinction, 2003 - 2007
Certifications & Licensure
- IN State Medical License 2014 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
- National Board of EchocardiographyBoard Certified in Echocardiography
Awards, Honors, & Recognition
- General Cardiology Fellowship Clinical Teacher of the Year Indiana University School of Medicine, 2021
- UT Southwestern Resident Teaching Award 2014
Publications & Presentations
PubMed
- Heparin Dosing During Percutaneous Coronary Intervention and Obesity.Rolf P Kreutz, Isaac G Leon, Eric R Bain, Bistees George, Sujoy Phookan
Journal of Cardiovascular Pharmacology. 2024-03-01 - 5 citationsCirrhotic cardiomyopathy: Predictors of major adverse cardiac events and assessment of reversibility after liver transplant.Saad A Ali, Huseyin E Arman, Hani Shamseddeen, Nathaniel Elsner, Hussein Elsemesmani
Journal of Cardiology. 2023-08-01 - Postliver transplant acute cardiomyopathy: Role of prospective cardiac evaluation in immediate posttransplant period.Zachary P Rokop, Joseph Zenisek, Kyle Frick, Richard S Mangus, Lava Timsina
Liver Transplantation. 2023-07-01
Press Mentions
- More Cases of Broken Hearts Showing up at Emergency RoomsFebruary 12th, 2021
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: